with financial results like this... this company drugs come out way too late to make a dollars... they keep reinventing the wheel by blowing share holders money... better of developing a totally new drug which doesn't exists... At least directors got paid well for the company losses...
A investor needs a lot of hope or luck to hold this stock after 4 straight years of losses
Group Performance
(Loss) before tax ($’000) :
2017 (94)
2018 (16,125)
2019 (8,335)
2020 (9,385)
Ann: Acrux Receives FDA Approval - Generic Testosterone Solution, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.6¢ | $1.303K | 79.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 187934 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 14.24pm 07/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |